• Congratulations to Dr. Michael Rowley Who Will be Inducted into the Hall of Fame of ACS Division of Medicinal Chemistry

    2nd August, 2017

    Dr. Michael  Rowley, Senior Vice President, Pharmaron Drug Discovery Services Europe, will be inducted into the Hall of Fame of ACS Division of Medicinal Chemistry at the Washington ACS meeting. The induction ceremony will be held on Tuesday, August 22, 2017, from 5:30 – 7:30 p.m., at the Washington Convention Center. Dr. Michael Rowley, together […]

    Read More
  • Pharmaron Acquires Majority Stake in SNBL CPC

    28th February, 2017

    Pharmaron Acquires Majority Stake in SNBL CPC Acquisition expands Pharmaron’s integrated offerings to clinical development phase Beijing, February 28, 2017 — Pharmaron, a fully integrated contract research organization offering R&D services to the life sciences industry, today announced that it has signed a definitive agreement under which Pharmaron will acquire a majority stake in Shin […]

    Read More
  • Pharmaron Holds Hoddesdon UK Opening Ceremony and Symposium on Synthetic and Medicinal Chemistry

    13th February, 2017

    Feb. 10, 2017, UK – Pharmaron has completed the acquisition of the Hoddesdon UK facility from Merck Sharpe & Dohme Limited (MSD), which includes MSD’s process research and development facility. To recognize the company expansion in the UK, an opening ceremony and symposium was held. The symposium, which included world-class guest speakers from academia and […]

    Read More
  • Pharmaron acquires Xceleron Inc.

    10th January, 2017

    Pharmaron acquires Xceleron Inc. Acquisition expands Pharmaron’s radiolabelled sciences capabilities   Beijing, January 10, 2017 __ Pharmaron, a fully integrated contract research organization offering R&D services for the life science industry, today announced the acquisition of Xceleron Inc. Xceleron is a Maryland, US-based globally leading Accelerator Mass Spectrometry (AMS) specialist for life sciences. The AMS […]

    Read More
  • Pharmaron and MSD agree deal to acquire MSD’s UK Hoddesdon site

    26th September, 2016

    Pharmaron and MSD agree deal to acquire MSD’s UK Hoddesdon site MSD to continue to remain on site and lease the main office buildings as part of a shared site agreement Beijing, September 26, 2016 Pharmaron has entered into a non-binding Heads of Terms (HoTs) with Merck Sharpe & Dohme Limited (MSD) for the sale […]

    Read More